Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 567-575

  Masotti, Luca ^a   Righini, Marc ^b   Vuilleumier, Nicolas ^b   Antonelli, Fabio ^a   Landini, Giancarlo ^c   Cappelli, Roberto ^d   Ray, Patrick ^e  

^a Internal Medicine Cecina Hospital   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

BNP; Computer tomography; Echocardiography; NT proBNP; Prognosis; Pulmonary embolism; Troponin

Indexed keywords

ALTEPLASE; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; FONDAPARINUX; GROWTH DIFFERENTIATION FACTOR 15; LOW MOLECULAR WEIGHT HEPARIN; MYOGLOBIN; STREPTOKINASE; TROPONIN I; TROPONIN T; UROKINASE; BIOLOGICAL MARKER;

BLOOD GAS ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EMBOLECTOMY; HUMAN; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; TRANSTHORACIC ECHOCARDIOGRAPHY; ACUTE DISEASE; BLOOD; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; HOSPITALIZATION; METHODOLOGY; MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ACUTE DISEASE; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 70350510636     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s4861     Document Type: Review

References (99)

1. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(Suppl 1):I4-8.
2. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax. 2003;58:470-484.
3. ESC Task Force. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J. 2000;21:1301-1336.
4. Tapson VF, Carroll BA, Davidson BL, et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999;160:1043-1066.
5. American College of Emergency Physicians Clinical Policies Committee; Clinical Policies Committee Subcommittee on Suspected Pulmonary Embolism. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med. 2003;41:257-270.
6. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I. Epidemiology, pathophysiology, and diagnosis. Circulation. 2003;108:2726-2729.
7. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med. 2006;119:1048-1055.
8. Writing Group for Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computer tomography. JAMA. 2006;295:172-179.
9. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144:165-171.
10. Becattini C, Agnelli G. Acute pulmonary embolism: risk stratification in the emergency department Intern Emerg Med. 2007;2:119-129.
11. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386-1389.
12. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology. Eur Heart J. 2008;29:2276-2315.
13. Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob GE, Comerota AJ. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454S-545S.
14. Kovacs MJ, Anderson D, Morrow B, et al. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost. 2000;83:209-211.
15. Beer JH, Burger M, Gretener S, Bernard Bagattini S, Bounameaux H. Outpatients treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost. 2003;1:186-187.
16. Aujesky D, Perrier A, Roy PM, et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med. 2007;261:597-604.
17. Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000;84:548-552.
18. Jimenez D, Yusen RG, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007;132:24-30.
19. Toosi MS, Merlino JD, Leeper KV. Prognostic value oft he shock index along with thransthoracic echocardiography in risk stratification of patients with pulmonary embolism. Am J Cardiol. 2008;101:700-705.
20. Otero R, Trujillo-Santos J, Cayuela A, et al. Registro Informatizado de la Enfermedad Tromboembolica (RIETE) Investigators. Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index? Eur Respir J. 2007;30:1111-1116.
21. Jimenez D. ECG for risk stratification in patients with pulmonary embolism. Eur Respir J. 2005;26:366-367.
22. Toosi MS, Merlino JD, Leeper KV. Electrocardiographic score and short term outcomes of acute pulmonary embolism. Am J Cardiol. 2007;100:1172-1176.
23. Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M. QR in V1-an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. Eur Heart J. 2003;24:1113-1119.
24. Goldhaber SZ. Echocardiography in the management of pulmonary embolism. Ann Intern Med. 2002;136:691-700.
25. Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest. 2004;125:1539-1545.
26. Vieillard-Baron A, Page B, Augarde R, et al. Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med. 2001;27:1481-1486.
27. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mmHg or higher. Arch Intern Med. 2005;165:1777-1781.
28. Kaczynska A, Kostrubiec M, Pacho R, Kunikowska J, Pruszczyk P. Elevated D-Dimer concentration identifies patients with incomplete recanalization of pulmonary artery thromboemboli despite 6 months after the first episode of acute pulmonary embolism. Thromb Res. 2008;122:21-25.
29. Frémont B, Pacouret G, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1,416 patients. Chest. 2008;133:358-362.
30. Gibson N, Sohne M, Buller H. Prognostic value of echocardiography and spiral computer tomography in patients with pulmonary embolism. Curr Opin Pulm Med. 2006;11:380-384.
31. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995;30:1276-1282.
32. ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism Arch Intern Med. 2004;164:1685-1689.
33. Ghaye B, Ghuysen A, Bruyere PJ, D'Orio V, Dondelinger RF. Can CT pulmonary angiography allow assessment of severity and prognosis in patients presenting with pulmonary embolism? What the radiologist needs to know. Radiographics. 2006;26:23-40.
34. Araoz PA, Gotway MB, Harrington JR, Harmsen WS, Mandrekar JN. Pulmonary embolism: prognostic CT findings. Radiology. 2007;242:889-897.
35. Schoepf UJ, Castello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology. 2004;230:329-337.
36. van der Meer RW, Pattynama PM, van Strijen MJ, et al. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology. 2005;235:798-803.
37. Ghuysen A, Ghaye B, Willems V, et al. Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism. Thorax. 2005;60:956-961.
38. Mansencal N, Joseph T, Vieillard-Baron A, et al. Diagnosis of right ventricular dysfunction in acute pulmonary embolism using helical computed tomography. Am J Cardiol. 2005;95:1260-1263.
39. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation. 2004;110:3276-3280.
40. Qanadli SD, El Hajjam M, Viellard-Baron A, et al. New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol. 2001;176:1415-1420.
41. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM. The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE. J Intern Med. 2007;261:74-81.
42. Wu AS, Pezzullo JA, Cronan JJ, Hou DD, Mayo-Smith WW. CT pulmonary angiography: quantification of pulmonary embolus as a predictor of patient outcome-initial experience. Radiology. 2004;230:831-835.
43. Masotti L, Antonelli F, Venturini E, Landini GC. Cardiac troponin I and plasma D-dimer are related to proximal and bilateral extension of clots and right cardiac dysfunction in patients with pulmonary embolism. J Intern Med. 2007;262:588-589.
44. Stein PD, Beemath A, Matta F, et al. Enlarged right ventricle without shock in acute pulmonary embolism: prognosis. Am J Med. 2008;121:34-42.
45. Stein PD, Woodard PK, Hull RD, et al. Gdolinium-enhanced magnetic resonance angiography for detection of acute pulmonary embolism. Chest. 2003;124:2324-2328.
46. Haage P, Piroth W, Krombach G, et al. Pulmonary embolism. Comparison of angiography with spiral computer tomography, magnetic resonance angiography, and real-time magnetic resonance imaging. Am J Respir Crit Care Med. 2003;167:729-734.
47. Pleszewski B, Chartrand-Lefebvre C, Qanadli SD, et al. Gadoliniumenhanced pulmonary magnetic resonance angiography in the diagnosis of acute pulmonary embolism: a prospective study on 48 patients. Clin Imaging. 2006;30:166-172.
48. Blum A, Bellou A, Guillemin F, et al. Performance of magnetic resonance angiography in suspected acute pulmonary embolism. Thromb Haemost. 2005;93:503-511.
49. Kluge A, Muller C, Hansel J, Gerriets T, Bachmann G. Real-time MR with TrueFISP for the detection of acute pulmonary embolism: initial clinical experience. Eur Radiol. 2004;14:709-718.
50. Bova C, Pesavento R, Marchiori A, et al. Risk stratification and outcomes in hemodinamically stable patients with acute pulmonary embolism. A prospective, multicentre, cohort study with three months of follow-up. J Thromb Hemost. 2009 Mar 19. [Epub ahead of print].
51. Hsu JT, Chu CM, Chang ST, et al. Prognostic value of arterial/alveolar oxygen tension ratio (a/APO2) in acute pulmonary embolism. Circ J. 2007;71:1560-1566.
52. Hsu JT, Chu CM, Chang ST, et al. Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism. Circ J. 2006;70:1611-1616.
53. Kline JA, Kubin AK, Patel MM, Easton EJ, Seupal RA. Alveolar dead space as a predictor of severity of pulmonary embolism. Acad Emerg Med. 2000;7:611-617.
54. Masotti LO, Ceccarelli E, Cappelli R, Barabesi L, Forconi S. Arterial blood gas analysis and alveolar-arterial oxygen gradient in diagnosis and prognosis of elderly patients with suspected pulmonary embolism. J Gerontol A Biol Sci Med Sci. 2000;55A:M760-M764.
55. Ghanima W, Abdelnoor M, Holmen LO, Nielsen BE, Ross S, Sandset PM. D-Dimer level is associated with the extent of pulmonary embolism. Thromb Res. 2007;120:281-288.
56. Aujesky D, Roy PM, Guy M, Cornuz J, Sanchez O, Perrier A. Prognostic value of D-Dimer in patients with pulmonary embolism. Thromb Haemost. 2006;96:478-482.
57. De Monyè W, Sanson BJ, Mac Gillavry MR, et al. Embolus location affects the sensitivity of a rapid quantitative D-Dimer assay in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med. 2002;165:345-348.
58. Becattini C, Vedovati MC, Agnelli G. Diagnosis and prognosis of acute pulmonary embolism: focus on troponins. Expert Rev Mol Diagn. 2008;8:339-349.
59. Muller-Bardorff M, Weidtmann B, Giannitsis E, et al. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem. 2002;48:673-675.
60. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation. 2000;102:211-217.
61. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation. 2002;106:1263-1268.
62. Pruszczyk P, Bochowicz A, Torbicki A, et al. Cardiac troponin T monitoring identifies high risk group of normotensive patients with acute pulmonary embolism. Chest. 2003;123:1947-1952.
63. Janata K, Holzer M, Laggner AN, Mullner M. Cardiac troponin T in the severity assessment of patients with pulmonary embolism: cohort study. BMJ. 2003;326:312-313.
64. Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003;108:2191-2194.
65. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116:427-433.
66. Becattini C, Agnelli G. Predictors of mortality from pulmonary embolism and their influence on clinical management. Thromb Haemost. 2008;100:747-751.
67. Jimènez D, Diaz G, Molina J, et al. Troponin I and risk stratification of patients with acute non massive pulmonary embolism. Eur Respir J. 2008;31:847-853.
68. Ray P, Delerme S, Jourdain P, Chenevier-Gobeaux C. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department. QJM. 2008;101:831-843.
69. ten Wolde M, Tulevski II, Mulder JW, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003;107:2082-2084.
70. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003;107:2545-2547.
71. Kruger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J. 2004;147:60-65.
72. Kiely DG, Kenneby NS, Pirzada O, Batchelor SA, Struthers SA, Lipworth BJ. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med. 2005;99:1286-1291.
73. Söhne M, Ten Wolde M, Boomsma F, Reitsma JB, Douketis JD, Büller HR. Brain natriuretic peptide in hemodinamically stable acute pulmonary embolism. J Thromb Haemost. 2006;4:552-556.
74. Pieralli F, Olivotto I, Vanni S, et al. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol. 2006;97:1386-1390.
75. Ray P, Maziere F, Medimagh S, et al. Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65 years and older: a brief report. Am J Emerg Med. 2006;26:603-607.
76. Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med. 2007;33:286-292.
77. Tulevski II, ten Wolde M, van Veldhuisen DJ, et al. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism. Int J Cardiol. 2007;116:161-166.
78. Vuilleumier N, Righini M, Perrier A, et al. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res. 2008;121:617-624.
79. Yardan T, Altintop L, Baydin A, Yilmaz O, Guven H. B-type natriuretic peptide as an indicator of right ventricular dysfunction in acute pulmonary embolism. Int J Clin Pract. 2008;62:1177-1182.
80. Pruszczyk P, Kostrubiec M, Bochowicz A, et al. N-terminal natriuretic peptide in patients with acute pulmonary embolism. Eur Repir J. 2003;22:649-653.
81. Kostrubiec M, Pruszczyk P, Bochowicz A, et al. Biomarker-based strategy risk assessment model in acute pulmonary embolism. Eur Heart J. 2005;26:2166-2172.
82. Kostrubiec M, Pruszczyk P, Kaczynska A, Kucher N. Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death. Clin Chim Acta. 2007;382:124-128.
83. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J. 2008;156:308-314.
84. Binder L, Pieske B, Olschewski M, et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation. 2005;112:1573-1579.
85. Maziere F, Birolleau S, Medimagh S, et al. Comparison of troponin I and N-terminal-pro B-type natriuretic peptide for risk stratification in patients with pulmonary embolism. Eur J Emerg Med. 2007;14:207-211.
86. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med. 2008;178:425-430.
87. Coutance G, Le Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care. 2008;12:R109.
88. Cavallazzi R, Nair A, Vasu T, Marik PE. Natriuretic peptides in acute pulmonary embolism: a systematic review. Intensive Care Med. 2008;34:2147-2156.
89. Sanchez O, Tringuart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J. 2008;29:1569-1577.
90. Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J. 2007;28:224-229.
91. Kaczyñska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006;371:117-123.
92. Pruszczyk P, Bochowicz A, Kostrubiec M, et al. Myoglobin stratifies short-term risk in acute major pulmonary embolism. Clin Chim Acta. 2003;338:53-56.
93. Lankeit M, Kempf T, Dellas C, et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2008;177:1018-1025.
94. Vuilleumier N, Righini M, Perrier A, et al. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res. 2008;121:617-624.
95. Vuilleumier N, Le Gal G, Verschuren F, et al. Cardiac biomarkers for risk stratification in non massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost. 2009;7:391-398.
96. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95:948-954.
97. Donzé J, Le Gal G, Fine M, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008;100:943-948.
98. Safety Study of Outpatient Treatment for Pulmonary Embolism (OTPE). NCT00425542. January 15, 2009. Accessed on March 1, 2009. Available from http://www.clinicaltrial.gov/.
99. PEITHO Pulmonary Embolism Thrombolysis Trial. NCT00639743. May 26, 2008. Accessed on March 1, 2009. Available from http://www. clinicaltrial.gov/.